In a significant/important/landmark development for the treatment of spinal muscular atrophy (SMA), the Delhi High Court has upheld/approved/supported the regulatory approval/permission/sanction for the drug risdiplam https://miriamuwhn624468.blognody.com/43073170/delhi-high-court-upholds-official-permission-for-risdiplam-in-india